{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-044952","form_type":"8-K","ticker":"BTAI","cik":"0001720893","company_name":"BioXcel Therapeutics, Inc.","filed_at":"2026-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.807097+00:00","generated_at":"2026-05-15T05:33:41.574554+00:00","sec_items":["3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioXcel Therapeutics issues warrants to purchase 1.35M shares at $0.01 per share under credit amendment","bullets":["On April 15, 2026, BioXcel Therapeutics granted lenders warrants to purchase up to 1,353,729 shares of common stock at an exercise price of $0.01 per share.","The warrants were issued pursuant to the Ninth Amendment to the Credit Agreement and Guaranty, dated April 19, 2022.","The Company also entered into a Fourth Amended and Restated Registration Rights Agreement with the lenders to register shares underlying the warrants.","The lenders include entities such as Oaktree-TCDRS Strategic Credit, LLC, Oaktree Specialty Lending Corporation, and others.","The warrants expire on the seventh anniversary of issuance and were issued in reliance on Section 4(a)(2) of the Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-044952","json":"https://secwatch.observer/filing/0001104659-26-044952.json","markdown":"https://secwatch.observer/filing/0001104659-26-044952.md","text":"https://secwatch.observer/filing/0001104659-26-044952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720893/000110465926044952/0001104659-26-044952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720893/000110465926044952/tm2612008d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-15T05:33:41.574554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}